Clinical Introduction of Stem Cell Sparing Radiotherapy to Reduce the Risk of Xerostomia in Patients with Head and Neck Cancer
Stem cell sparing radiotherapy can be clinically introduced by making small adjustments to the optimization strategy and can reduce the risk of xerostomia.
Authors
- Johannes A. Langendijk (ORCID: https://orcid.org/0000-0003-1083-372X)
- Frank Hoebers (ORCID: https://orcid.org/0000-0002-4317-9181)
- A. Arents-Huls
- A. van der Schaaf (ORCID: https://orcid.org/0000-0003-4067-7975)
- Rachel Ger (ORCID: https://orcid.org/0000-0003-1244-7160)
- R.J.H.M. Steenbakkers
- Maria I. van Rijn–Dekker (ORCID: https://orcid.org/0000-0002-2803-8997)
- Peter van Luijk (ORCID: https://orcid.org/0000-0001-7959-1234)
- S. Vigorito (ORCID: https://orcid.org/0000-0002-4017-1707)
- Olga Hamming‐Vrieze (ORCID: https://orcid.org/0000-0001-5928-4704)
- Mischa de Ridder (ORCID: https://orcid.org/0000-0002-2530-3038)
- Ellen M. Zwijnenburg (ORCID: https://orcid.org/0000-0002-1727-8215)
- Sanne W. Nienhuis
Institutions
- University Medical Center Groningen (NL)
- Radboud University Nijmegen (NL)
- University of Groningen (NL)
- Radboud University Medical Center (NL)
- The Netherlands Cancer Institute (NL)
- University Medical Center Utrecht (NL)
- Maastricht University (NL)
- Radiotherapiegroep (NL)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Maastro Clinic (NL)
- European Institute of Oncology (IT)
Publication Details
- Journal
- Cancers
- Published
- 2024-12-23
- DOI
- https://doi.org/10.3390/cancers16244283
- Citations
- 1
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.58
Funders
- KWF Kankerbestrijding